Liver tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) 18 years old = age = 75 years old, regardless of gender; (2) patients who required hepatectomy according to the investigator's judgment; (3) be able to cooperate and complete follow-up and related examinations; (4) voluntarily participated in this study and signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Pregnant or lactating women; (2) Severe coagulation dysfunction, obvious bleeding tendency (platelets < 100x10 9 PCS /L); (3) History of major abdominal surgery, intraperitoneal adhesion difficult to separate exposed lesions; (4) There are serious complications that cannot tolerate pneumoperitoneum, surgery or anesthesia; (5) Combined with surgical site or systemic infection, severe inflammatory reaction; (6) The lesion is adjacent to or directly invading the large blood vessels; (7) The important structure of the hilar is invaded, or the need to expand the retroperitoneal lymph node dissection; (8) Patients with liver cancer: CNLC stage Ib and above; (9) Emergency surgery; (10) Spontaneous rupture and hemorrhage of primary liver cancer; (11) Participants in other investigational drug or device clinical trials have not been completed; (12) Patients considered unsuitable for participation in this project by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| No conversion rate;Overall incidence of surgical complications; | — |
Secondary
| Measure | Time frame |
|---|---|
| Complication incidence rate intraoperative bleeding volume and intraoperative blood transfusion volume;operative time;Postoperative pain score;Equipment defect incidence rate;postoperative hospitalization time;The incidence of device related or potentially related complications;Drainage volume within 24 hours after surgery;Laboratory Examination;AE/SAE; | — |
Countries
China
Contacts
Peking University First Hospital